September 1, 2006Open Access

Evaluation of inactivation methods for severe acute respiratory syndrome coronavirus in noncellular blood products

MDMiriam E. R. DarnellOffice of Extramural Research DTDeborah R. TaylorUniversity Hospital Southampton NHS Foundation Trust

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Heat, UVC irradiation, and S/D treatments effectively inactivate SARS-CoV, whereas octanoic acid treatment is insufficient for inactivation of the virus.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Darnell et al. (Fri,) studied this question.

synapsesocial.com/papers/69d8354da2a48916bbbef66a https://doi.org/https://doi.org/10.1111/j.1537-2995.2006.00976.x

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Distribution and Repair of Bipyrimidine Photoproducts in Solar UV-irradiated Mammalian Cells2000 · 246 citations
2Effect of manufacturing process parameters on virus inactivation by solvent–detergent treatment in a high‐purity factor IX concentrate2003 · 14 citations
3Viral safety of solvent/detergent-treated blood products1994 · 98 citations
4Distribution and repair of bipyrimidine photoproducts in solar UV-irradiated mammalian cells. Possible role of Dewar photoproducts in solar mutagenesis2000 · 230 citations
5Pathogen inactivation technology: cleansing the blood supply2005 · 96 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo